Paragonix Technologies receives FDA 510(k) clearance for KidneyVault portable renal perfusion system
Paragonix Technologies, a leading organ preservation company recently acquired by Getinge, receives FDA clearance for the innovative transportable perfusion device KidneyVault, to optimize standard of care in kidney preservation.Getinge’s most recent acquisition, Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, has received US Food and Drug Administration (FDA) 510(k) clearance for its donor kidney preservation system, KidneyVault. The KidneyVault System is Paragonix’s first perfusion device, integrating its streamlined digital monitoring